Skip to main content

Dr. Shira Lipton

Dr. Shira Lipton

Board Certified Dermatologist

Dermatology Expertise, Translated.

Rigorous dermatology insight for the companies building what comes next.

Stanford and UCSF Trained 

Chief Medical Officer, Supportive Dermato-Oncology, Palo Alto Medical Foundation / Sutter Health

Advisory Board, Medical Advisor, MoxieDerm Therapeutics

Upcoming Presentations: Acute and Chronic Radiation Dermatitis: Pathophysiology, Management, and What Community Clinicians Should Know. San Francisco Dermatology Society.

Recent Papers: What Radiology Teaches Dermatology About AI:
Benchmarks, Bedside, and the Gap Between

BOARD-CERTIFIED

10+ YEARS EXPERIENCE

Stanford UCSF Trained

Areas of Expertise

Advisory Board Work

Providing strategic guidance, expert insight, and collaborative leadership to advance healthcare innovation, education, and patient-centered outcomes.

Media Support

Offering expert medical perspectives and thought leadership for media outlets, interviews, podcasts, and public discussions.

White Papers / Manuscripts

Developing research-driven publications that translate complex healthcare topics into actionable insights for professionals, organizations, and communities.

Ready to put your skin first?

Schedule a consultation with Dr. Lipton and take the first step toward healthier, more radiant skin. We’re accepting new patients.

Phone

(212) 555-0142

Email

drshiralipton@gmail.com

Location

780 Park Avenue, Suite 1A

Office Hours

Monday – Thursday8:30am – 5:30pm
Friday8:30am – 4:00pm
Saturday9:00am – 1:00pm
SundayClosed

Request an Appointment

What our patients are saying

Medical Advisor

Much health technology struggles not because the engineering is weak, but because the product misreads clinical reality. That gap between a promising idea and daily dermatology practice is exactly where Dr. Lipton wants to contribute.

A board-certified, practicing dermatologist, she is actively building an advisory practice serving health AI startups, device manufacturers, and life science companies. What she brings is the substance of clinical work itself: firsthand knowledge of how dermatologists evaluate patients, make treatment decisions, and move through diagnostic workflows — and a habit of asking whether the evidence supports the claim.

She is eager to engage across the questions that shape a product’s clinical future: whether the unmet need is real, which use cases make clinical sense, how a study should be designed to answer the questions physicians will ask, and how a team can present its science credibly to providers, investors, and partners.

She will tell companies what she sees, including when the answer is inconvenient. That is the point of having a clinician in the room.